ISB News

ISB at Eastside Science Cafe

Personal Genome Sequencing Discussion at Eastside Science Cafe.

Jared Roach, Ph.D., M.D., Institute for Systems Biology, will be presenting at Eastside Science Cafe:
Monday, 11 February 2013 – 7:00pm

Location:
Wilde Rover, Kirkland Click here for Map

The first personal genomes were sequenced only five years ago and cost millions of dollars. Personal genome sequencing is now a thousand times cheaper, and many people are considering sequencing their own genomes to help answer a variety of questions, covering topics ranging from their ancestry to their health. At the February Eastside Science Café, join the Institute for Systems Biology’s Jared Roach, M.D., Ph.D., to explore some of the new knowledge about the genome. Download the PDF flyer.

Eastside Science Café is held on the second Monday of each month. Did you miss a café and want to hear the discussion? Most Science Cafés are recorded by KCTS 9 and are available for online viewing. Eastside Science Cafés take place at Wilde Rover in Kirkland and are presented in partnership with Pacific Science Center and KCTS 9.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.